865
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Patients’ and caregivers’ perspectives of the atopic dermatitis journey

, , , , , , & show all
Article: 2315145 | Received 26 Sep 2023, Accepted 01 Feb 2024, Published online: 22 Feb 2024

References

  • Brown SJ. Atopic eczema. Clin Med. 2016;16(1):1–13. doi: 10.7861/clinmedicine.16-1-66.
  • Fleming P, Yang YB, Lynde C, et al. Diagnosis and management of atopic dermatitis for primary care providers. J Am Board Fam Med. 2020;33(4):626–635. doi: 10.3122/jabfm.2020.04.190449.
  • Maliyar K, Sibbald C, Pope E, et al. Diagnosis and management of atopic dermatitis: a review. Adv Skin Wound Care. 2018;31(12):538–550. doi: 10.1097/01.ASW.0000547414.38888.8d.
  • Urban K, Chu S, Giesey RL, et al. The global, regional, and national burden of atopic dermatitis in 195 countries and territories: an ecological study from the Global Burden of Disease Study 2017. JAAD Int. 2021;2:12–18. doi: 10.1016/j.jdin.2020.10.002.
  • Luger TA, Hebert AA, Zaenglein AL, et al. Subgroup analysis of crisaborole for mild-to-moderate atopic dermatitis in children aged 2 to < 18 years. Pediatr Drugs. 2022;24(2):175–183. doi: 10.1007/s40272-021-00490-y.
  • Baron SE, Cohen SN, Archer CB. Guidance on the diagnosis and clinical management of atopic eczema. Clin Exp Dermatol. 2012;37(Suppl 1):7–12. doi: 10.1111/j.1365-2230.2012.04336.x.
  • Kapur S, Watson W, Carr S. Atopic dermatitis. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):52. doi: 10.1186/s13223-018-0281-6.
  • Al-Naqeeb J, Danner S, Fagnan LJ, et al. The burden of childhood atopic dermatitis in the primary care setting: a report from the Meta-LARC consortium. J Am Board Fam Med. 2019;32(2):191–200. doi: 10.3122/jabfm.2019.02.180225.
  • Johnson BB, Franco AI, Beck LA, et al. Treatment-resistant atopic dermatitis: challenges and solutions. Clin Cosmet Investig Dermatol. 2019;12:181–192. doi: 10.2147/CCID.S163814.
  • Nowicki RJ, Trzeciak M, Kaczmarski M, et al. Atopic dermatitis. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society, Polish Society of Allergology, Polish Pediatric Society and Polish Society of Family Medicine. Part I. Prophylaxis, topical treatment and phototherapy. Postepy Dermatol Alergol. 2020;37(1):1–10. doi: 10.5114/ada.2020.93423.
  • Tier HL, Balogh EA, Bashyam AM, et al. Tolerability of and ­adherence to topical treatments in atopic dermatitis: a narrative review. Dermatol Ther. 2021;11(2):415–431. doi: 10.1007/s13555-021-00500-4.
  • Eicher L, Knop M, Aszodi N, et al. A systematic review of factors influencing treatment adherence in chronic inflammatory skin disease - strategies for optimizing treatment outcome. J Eur Acad Dermatol Venereol. 2019;33(12):2253–2263. doi: 10.1111/jdv.15913.
  • Siegfried EC, Paller AS, Mina-Osorio P, et al. Effects of variations in access to care for children with atopic dermatitis. BMC Dermatol. 2020;20(1):24. doi: 10.1186/s12895-020-00114-x.
  • Hester T, Thomas R, Cederna J, et al. Increasing access to specialized dermatology care: a retrospective study investigating clinical operation and impact of a university-affiliated free clinic. Dermatol Ther. 2021;11(1):105–115. doi: 10.1007/s13555-020-00462-z.
  • Glazer AM, Farberg AS, Winkelmann RR, et al. Analysis of trends in geographic distribution and density of US dermatologists. JAMA Dermatol. 2017;153(4):322–325. doi: 10.1001/jamadermatol.2016.5411.
  • Bisgaier J, Rhodes KV. Auditing access to specialty care for children with public insurance. N Engl J Med. 2011;364(24):2324–2333. doi: 10.1056/NEJMsa1013285.
  • Skinner AC, Mayer ML. Effects of insurance status on children’s access to specialty care: a systematic review of the literature. BMC Health Serv Res. 2007;7(1):194. doi: 10.1186/1472-6963-7-194.
  • McKenna SP, Doward LC. Quality of life of children with atopic dermatitis and their families. Curr Opin Allergy Clin Immunol. 2008;8(3):228–231. doi: 10.1097/ACI.0b013e3282ffd6cc.
  • de Wijs LEM, van Egmond S, Devillers ACA, et al. Needs and preferences of patients regarding atopic dermatitis care in the era of new therapeutic options: a qualitative study. Arch Dermatol Res. 2022;315(1):75–83. doi: 10.1007/s00403-021-02321-z.
  • Koszoru K, Borza J, Gulacsi L, et al. Quality of life in patients with atopic dermatitis. Cutis. 2019;104(3):174–177.
  • Carroll CL, Balkrishnan R, Feldman SR, et al. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol. 2005;22(3):192–199. doi: 10.1111/j.1525-1470.2005.22303.x.
  • Bashyam AM, Ganguli S, Mahajan P, et al. Lifelong impact of severe atopic dermatitis on quality of life: a case report. Dermatol Ther. 2021;11(3):1065–1070. doi: 10.1007/s13555-021-00515-x.
  • Na CH, Chung J, Simpson EL. Quality of life and disease impact of atopic dermatitis and psoriasis on children and their families. Children. 20192;6(12):133. doi: 10.3390/children6120133.
  • Drucker AM. Atopic dermatitis: burden of illness, quality of life, and associated complications. Allergy Asthma Proc. 2017;38(1):3–8. doi: 10.2500/aap.2017.38.4005.
  • Huang J, Choo YJ, Smith HE, et al. Quality of life in atopic dermatitis in Asian countries: a systematic review. Arch Dermatol Res. 2022;314(5):445–462. doi: 10.1007/s00403-021-02246-7.
  • Frazier W, Bhardwaj N. Atopic dermatitis: diagnosis and treatment. Am Fam Physician. 2020;101(10):590–598.
  • Siegfried EC, Hebert AA. Diagnosis of atopic dermatitis: mimics, overlaps, and complications. J Clin Med. 2015;4(5):884–917. doi: 10.3390/jcm4050884.
  • Weidinger S, Nosbaum A, Simpson E, et al. Good practice intervention for clinical assessment and diagnosis of atopic dermatitis: findings from the atopic dermatitis quality of care initiative. Dermatol Ther. 2022;35(3):e15259.
  • Silverberg JI, Feldman SR, Smith Begolka W, et al. Patient perspectives of atopic dermatitis: comparative analysis of terminology in social media and scientific literature, identified by a systematic literature review. J Eur Acad Dermatol Venereol. 2022;36(11):1980–1990. doi: 10.1111/jdv.18442.
  • Burgener AM. Enhancing communication to improve patient safety and to increase patient satisfaction. Health Care Manag. 2020;39(3):128–132. doi: 10.1097/HCM.0000000000000298.
  • Lang EV. A better patient experience through better communication. J Radiol Nurs. 2012;31(4):114–119. doi: 10.1016/j.jradnu.2012.08.001.
  • Timmers T, Janssen L, Kool RB, et al. Educating patients by providing timely information using smartphone and tablet apps: systematic review. J Med Internet Res. 2020;22(4):e17342. doi: 10.2196/17342.
  • Pehrson C, Banerjee SC, Manna R, et al. Responding empathically to patients: development, implementation, and evaluation of a communication skills training module for oncology nurses. Patient Educ Couns. 2016;99(4):610–616. doi: 10.1016/j.pec.2015.11.021.
  • Wei W, Anderson P, Gadkari A, et al. Discordance between physician- and patient-reported disease severity in adults with atopic dermatitis: a US cross-sectional survey. Am J Clin Dermatol. 2017;18(6):825–835. doi: 10.1007/s40257-017-0284-y.
  • Wong ITY, Tsuyuki RT, Cresswell-Melville A, et al. Guidelines for the management of atopic dermatitis (eczema) for pharmacists. Can Pharm J. 2017;150(5):285–297. doi: 10.1177/1715163517710958.
  • Berruyer M, Delaunay J. Atopic dermatitis: a patient and dermatologist’s perspective. Dermatol Ther. 2021;11(2):347–353. doi: 10.1007/s13555-021-00497-w.
  • Eczema Society of Canada. The atopic dermatitis patient journey. Ontario (Canada): Eczema Society of Canada; 2020 [updated 2022 Aug 5; cited 2022 Sept 29].
  • Willems A, Tapley A, Fielding A, et al. General practice registrars’ management of and specialist referral patterns for atopic dermatitis. Dermatol Pract Concept. 2021;11(1):e2021118. doi: 10.5826/dpc.1101a118.
  • Azizan NZ, Ambrose D, Sabeera B, et al. Management of atopic eczema in primary care. Malays Fam Phys. 2020;15(1):39–43.
  • Arkwright PD, Motala C, Subramanian H, et al. Management of difficult-to-treat atopic dermatitis. J Allergy Clin Immunol Pract. 2013;1(2):142–151. doi: 10.1016/j.jaip.2012.09.002.
  • Suarez-Lledo V, Alvarez-Galvez J. Prevalence of health misinformation on social media: systematic review. J Med Internet Res. 2021;23(1):e17187.doi: 10.2196/17187.